Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

65992 1510824253HCLSReviewUkraineNovember2017.pdf
Energy Boardroom

Type your email in the box below to read this content NOW:

Interview

Weng Si Ho – Director of Biomedical Sciences, EDB, Singapore

28.09.2016 / Pharmaboardroom

weng-si-hi-director-bms-edbAttract, Transform, and Create. The Singapore Economic Development Board’s (EDB) director of biomedical sciences, Weng Si Ho highlights these three actions as the primary strategic focuses of the organization from this point forward and explains how, ultimately, they serve to help sustain Singapore’s future value proposition to healthcare and life science companies.

What items have been occupying the bulk of your agenda since assuming this role in January 2016?

Singapore has done well to date, but now the question is how do we remain competitive and evolve alongside the industry’s own development? Healthcare models are shifting, particularly with aging populations and increasingly pervasive chronic diseases. In Singapore, it is about creating the right environment so that companies can benefit from the capabilities that we have built. Companies then adopt and pivot to new healthcare models, in order to continue growing their businesses.

LATEST ISSUE

DOWNLOAD

Most Read

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: